drugset / Trial / NCT05246046

Comparison of Tiotropium Absorption From Tiotropium Easyhaler and Spiriva HandiHaler

NCT05246046

Phase 1 Completed 88 enrolled Orion Corporation, Orion Pharma
RandomizedCrossoverOpen-labelBasic science

Summary

This is a pivotal study to investigate absorption of inhaled tiotropium from 2 Tiotropium Easyhaler product variants and Spiriva capsules inhaled via HandiHaler.

Timeline

Start
2022-02-16
Primary completion
2022-08-03
Completion
2022-08-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Tiotropium Other / unclassified 20 ug Inhaled

Indications

No indication recorded.